肠-关节轴:双菌细胞壁脂蛋白对关节炎发展的影响
Frank Piva1, Philippe Gervois1, Youness Karrout2
1Virology Laboratory-ULR3610, University of Lille and CHU Lille, 59000 Lille, France.
Nutrients
|December 9, 2023
概括
在特定的剂量下,Bifidobacterium longum脂蛋白 (Lpps) 通过调节肠道细菌和免疫反应来预防类风湿性关节炎 (RA). 最佳的Lpps剂量对于预防RA进展和免疫系统调节至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 类风湿病学 类风湿病学
背景情况:
- 类风湿性关节炎 (RA) 的进展受肠道微生物群的影响.
- 双长菌的细胞壁脂蛋白 (Lpps) 调节肠道微生物群,并显示出预防关节炎的潜力.
研究的目的:
- 研究Bifidobacterium longum细胞壁脂蛋白 (Lpps) 在类风湿性关节炎 (RA) 中的保护潜力.
- 在RA模型中确定Lpps对肠道微生物群组成和免疫反应的影响.
主要方法:
- 在小鼠中使用原诱导性关节炎 (CIA) 或抗原抗体 (CAIA) 模型诱导关节炎.
- 给小鼠服用不同剂量的Lpps (0.25,0.5和1 mg/L).
- 分析了肠道微生物群的组成,免疫细胞群 (树突细胞),细胞因子的产生 (IL-10),以及组织中的Lpps分布.
主要成果:
- 特定剂量为0.5 mg/L Lpps显著缓解了CIA小鼠的RA症状,并降低了CAIA小鼠的关节炎指数 (AI).
- 治疗Lpps改变了肠道微生物群,增加了Ligilactobacillus murinus等有益细菌,并在受保护的小鼠中减少了大肠杆菌.
- 治疗Lpps导致免疫细胞配置的改变,包括减少脏树突细胞和增加IL-10分泌在保护小鼠的脏细胞.
结论:
- 对于有效预防关节炎进展和调节肠道微生物群来说,Lpps的剂量至关重要.
- Lpps可以调节肠道微生物群和免疫系统,为类风湿性关节炎提供潜在的治疗策略.
- 这项研究强调了Lpps在触发免疫系统对抗关节炎方面的潜力.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Inflammation
53.5K
Overview
53.5K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management
129
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
129
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
142
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
142
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335


